
Sign up to save your podcasts
Or


McDonald’s reports historically bad sales numbers. Merck buys Cubist Pharmaceuticals for $9.5 billion. And we dip into the Fool Mailbag to explore the future of fracking.
By The Motley Fool4.7
16041,604 ratings
McDonald’s reports historically bad sales numbers. Merck buys Cubist Pharmaceuticals for $9.5 billion. And we dip into the Fool Mailbag to explore the future of fracking.

3,228 Listeners

1,501 Listeners

806 Listeners

939 Listeners

531 Listeners

1,186 Listeners

2,190 Listeners

825 Listeners

1,432 Listeners

1,048 Listeners

9,718 Listeners

194 Listeners

829 Listeners

85 Listeners

47 Listeners

1,034 Listeners

50 Listeners